ESC 365 - Late Breaking Trials in ACS

ESC Premium Access

Late Breaking Trials in ACS

Event: ESC Congress 2021 - The Digital Experience

Topic: Acute Coronary Syndromes

Session type: Late-Breaking Science

Date: 27 August 2021

Time: 10:30 - 11:15

Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)

HUYGENS: Evolocumab and changes in plaque composition on OCT

Speaker: Professor S. Nicholls (Melbourne, AU)

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Speaker: Professor S. Zhou (Changsha, CN)

4 speakers from this session

Professor Gilles Montalescot

Sorbonne University, Paris (France)

23 presentations

1 follower

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)

34 presentations

1 follower

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

3 presentations

0 follower

Professor Shenghua Zhou

The Second Xiangya Hospital of Central South University, Changsha (China)

1 presentation

0 follower

This platform is supported by